Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Lynn H, Woodlief"'
Autor:
Eric J. Topol, Alan D. Guerci, Frank E. Harrell, G. I. Barbash, Robert M. Califf, Kerry L. Lee, Maarten L. Simoons, R.J. Simes, W D Weaver, Lynn H. Woodlief, Harvey D. White
Publikováno v:
American Heart Journal. 133:630-639
We developed a logistic regression model with data from the GUSTO-I trial to predict mortality rate differences in individual patients who received accelerated tissue plasminogen activator (TPA) versus streptokinase treatment for acute myocardial inf
Autor:
Philip E. Aylward, Barbara E. Tardiff, Robert M. Califf, Kerry L. Lee, Eric R. Bates, Cynthia L. Green, Lynn H. Woodlief, Amadeo Betriu, Wolfgang Rutsch, Eric J. Topol, Douglas C. Morris
Publikováno v:
Journal of the American College of Cardiology. 29(2):240-249
Objectives. This study sought to investigate the impact of surgical revascularization on outcome after myocardial infarction. Background. Small variations in rates of coronary artery bypass graft surgery (CABG) were noted among thrombolytic regimens
Autor:
Christopher B. Granger, Neal S. Kleiman, Lynn H. Woodlief, Lisa G. Berdan, Robert A. Harrington, Robert M. Califf
Publikováno v:
Journal of Thrombosis and Thrombolysis. 4:415-423
Background: The current prevalence, timing, and route of heparin use after thrombolytic therapy for acute myocardial infarction both within and outside the United States (U.S.) have not been extensively studied. Method: An 18-item questionnaire was m
Autor:
Frans Van de Werf, Phil Aylward, Jacques Col, Maarten L. Simoons, Kerry L. Lee, Robert M. Califf, Amadeo Betriu, Eric J. Topol, W. Douglas Weaver, Lynn H. Woodlief
Publikováno v:
Circulation. 91:1659-1668
Background Despite remarkable advances in the treatment of acute myocardial infarction, substantial early patient mortality remains. Appropriate choices among alternative therapies and the use of clinical resources depend on an estimate of the patien
Autor:
Eric J. Topol, Barry S. George, Harry R. Phillips, Cindy L. Grines, Robert M. Califf, William W. O'Neill, Jeffrey D. Leimberger, Dean J. Kereiakes, Lynn H. Woodlief
Publikováno v:
Circulation. 91:298-303
Background Smoking is known to be a strong risk factor for premature atherosclerosis, myocardial infarction, and sudden cardiac death. Unexpectedly, in the reperfusion era, investigators have reported that patients who smoke have a more favorable pro
Autor:
George Edward Taylor, Geoffrey Hartzler, Lynn H. Woodlief, Michelle Strzelecki, James E. Tcheng, Lisa G. Berdan, James O'Keefe, Bruce R. Brodie, William D. Knopf, Cindy L. Grines, Russell J. Ivanhoe, Richard A. Weintraub, William W. O'Neill, Robert M. Califf, Barton G. Sickinger
Publikováno v:
The American Journal of Cardiology. 73:627-633
During a 14-month period, 6 experienced centers prospectively enrolled 271 patients into a registry in which percutaneous transluminal coronary angioplasty was the primary treatment for acute myocardial infarction. Patients age18 years who presented
Autor:
Stephen G. Ellis, Kristina N. Sigmon, Dean J. Kereiakes, Thomas C. Wall, Eric J. Topol, Robert M. Califf, Lynn H. Woodlief, Jeffrey L. Anderson, Jeffrey J. Popma, Joseph Samaha, Barry S. George, David C. Stump, Seth J. Worley
Publikováno v:
Journal of the American College of Cardiology. 20(6):1305-1312
Objectives. The goal of this study was to lend insight into the mechanisms responsible for the beneficial effects of combination thrombolytic therapy. Background. Combination thrombolytic therapy for acute myocardial infarction bas been associated wi
Autor:
Robert P, Giugliano, Matthew T, Roe, Robert A, Harrington, C Michael, Gibson, Uwe, Zeymer, Frans, Van de Werf, Kenneth W, Baran, Hans Peter, Hobbach, Lynn H, Woodlief, Karen L, Hannan, Sally, Greenberg, Joanne, Miller, Michael M, Kitt, John, Strony, Carolyn H, McCabe, Eugene, Braunwald, Robert M, Califf
Publikováno v:
Journal of the American College of Cardiology. 41(8)
The goal of this study was to evaluate combinations of eptifibatide with reduced-dose tenecteplase (TNK) in ST-elevation myocardial infarction (STEMI).Glycoprotein IIb/IIIa inhibitors enhance thrombolysis. The role of combination therapy in clinical
Publikováno v:
Controlled clinical trials. 18(6)
Auditing a clinical trial is a complex process designed to ensure that the trial will provide a reliable answer to the question being posed. Traditional auditing methods are expensive, and escalate the cost of clinical trials. This paper describes ap
Autor:
Robert M. Califf, Lynn H. Woodlief
Publikováno v:
European heart journal. 18(3)